Lamisil Dermgel

Terbinafine, the active ingredient in Lamisil Dermgel, is an allylamine antifungal presented as a topical Dermgel for cutaneous use. It works by inhibiting fungal cell membrane synthesis and is indicated for the treatment of superficial dermatophyte infections such as athlete's foot, jock itch and ringworm in both adults and children.

GNH USA supplies Lamisil Dermgel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide through regulated distribution channels, ensuring product integrity and compliance with local regulations.

Lamisil Dermgel (terbinafine) is used to treat dermatophyte infections of the skin. - Tinea pedis: resolves itching and scaling caused by athlete's foot. - Tinea cruris: reduces redness and inflammation associated with jock itch. - Tinea corporis: clears ring-shaped lesions of ringworm.

Terbinafine topical therapy may be associated with local and systemic adverse reactions. Common Side Effects: - Application site irritation: redness, burning or itching at the site of gel application. - Pruritus: mild itching unrelated to infection. - Dry skin: localized dryness or peeling. - Erythema: mild redness of the treated area. Serious or Rare Side Effects: - Contact dermatitis: severe allergic skin reaction with swelling and vesicles. - Hepatotoxicity: rare liver enzyme elevation requiring monitoring. - Stevens‑Johnson syndrome: extremely rare severe mucocutaneous reaction. - Systemic hypersensitivity: anaphylaxis or severe rash.

When using Lamisil Dermgel, several precautions should be observed to ensure safety and effectiveness. - Avoid use on broken skin: do not apply gel to open wounds or erosions. - Limit exposure to eyes: keep product away from ocular surfaces. - Monitor for allergic reaction: discontinue if severe rash or swelling occurs. - Use as directed: apply only the prescribed amount and frequency. - Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. - Store at room temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Terbinafine may interact with other medicines; awareness of potential interactions helps avoid reduced efficacy or increased toxicity. Major Interactions (Avoid): - CYP2D6 inhibitors: co‑administration with strong CYP2D6 inhibitors can increase terbinafine levels. - Antifungal agents: concurrent use with other systemic antifungals may enhance toxicity. Moderate Interactions (Monitor Closely): - Warfarin: terbinafine may potentiate anticoagulant effect, requiring INR monitoring. - Oral contraceptives: possible reduction in efficacy, advise alternative contraception. - Antidepressants metabolized by CYP2C9: monitor for altered plasma concentrations.